HLN
Price
$9.49
Change
-$0.12 (-1.25%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
42.94B
97 days until earnings call
Intraday BUY SELL Signals
RDY
Price
$14.05
Change
+$0.04 (+0.29%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
11.74B
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HLN vs RDY

Header iconHLN vs RDY Comparison
Open Charts HLN vs RDYBanner chart's image
Haleon
Price$9.49
Change-$0.12 (-1.25%)
Volume$186.9K
Capitalization42.94B
Dr. Reddy's Laboratories
Price$14.05
Change+$0.04 (+0.29%)
Volume$8.07K
Capitalization11.74B
HLN vs RDY Comparison Chart in %
HLN
Daily Signal:
Gain/Loss:
RDY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HLN vs. RDY commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a Hold and RDY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (HLN: $9.61 vs. RDY: $14.02)
Brand notoriety: HLN and RDY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 103% vs. RDY: 104%
Market capitalization -- HLN: $42.94B vs. RDY: $11.74B
HLN [@Pharmaceuticals: Generic] is valued at $42.94B. RDY’s [@Pharmaceuticals: Generic] market capitalization is $11.74B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileRDY’s FA Score has 0 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • RDY’s FA Score: 0 green, 5 red.
According to our system of comparison, RDY is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish while RDY’s TA Score has 5 bullish TA indicator(s).

  • HLN’s TA Score: 5 bullish, 4 bearish.
  • RDY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HLN is a better buy in the short-term than RDY.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а -2.44% price change this week, while RDY (@Pharmaceuticals: Generic) price change was +1.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Reported Earning Dates

HLN is expected to report earnings on Feb 25, 2026.

RDY is expected to report earnings on Jan 23, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($42.9B) has a higher market cap than RDY($11.7B). HLN has higher P/E ratio than RDY: HLN (21.87) vs RDY (17.71). HLN YTD gains are higher at: 1.438 vs. RDY (-10.463). RDY has higher annual earnings (EBITDA): 98.5B vs. HLN (2.71B). RDY has more cash in the bank: 69.8B vs. HLN (676M). HLN has less debt than RDY: HLN (8.45B) vs RDY (58.5B). RDY has higher revenues than HLN: RDY (342B) vs HLN (11B).
HLNRDYHLN / RDY
Capitalization42.9B11.7B367%
EBITDA2.71B98.5B3%
Gain YTD1.438-10.463-14%
P/E Ratio21.8717.71123%
Revenue11B342B3%
Total Cash676M69.8B1%
Total Debt8.45B58.5B14%
FUNDAMENTALS RATINGS
RDY: Fundamental Ratings
RDY
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
50
PRICE GROWTH RATING
1..100
71
P/E GROWTH RATING
1..100
43
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNRDY
RSI
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
48%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
43%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 7 days ago
55%
Bullish Trend 2 days ago
50%
Declines
ODDS (%)
Bearish Trend 15 days ago
53%
Bearish Trend 24 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
48%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signal:
Gain/Loss:
RDY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MYMJ24.85N/A
N/A
SPDR SSGA My2030 Municipal Bond ETF
TAXF50.55-0.02
-0.04%
American Century Divers Muncpl Bd ETF
FAAR30.66-0.19
-0.60%
First Trust Alt Abs Ret Strat ETF
EFAV84.49-0.57
-0.67%
iShares MSCI EAFE Min Vol Factor ETF
FTXH31.61-0.29
-0.90%
First Trust Nasdaq Pharmaceuticals ETF

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-1.04%
HLNCF - HLN
49%
Loosely correlated
-3.14%
TAK - HLN
40%
Loosely correlated
+0.14%
ZTS - HLN
33%
Loosely correlated
-0.90%
VTRS - HLN
31%
Poorly correlated
-2.43%
AVDL - HLN
29%
Poorly correlated
+0.72%
More

RDY and

Correlation & Price change

A.I.dvisor tells us that RDY and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+0.21%
TAK - RDY
32%
Poorly correlated
+0.14%
COLL - RDY
29%
Poorly correlated
-1.90%
HROW - RDY
28%
Poorly correlated
-0.30%
AVDL - RDY
27%
Poorly correlated
+0.72%
HLN - RDY
25%
Poorly correlated
-1.04%
More